The CD63 expression measured as basophil reactivity (maximal reactivity, CD-max) showed differences between clinically symptomatic (OAS/systemic) and sensitized subjects (Fig. 2a). The gene discussed is CD63; the disease is microphthalmia with limb anomalies.